In the News

New personalised therapeutics partner joins Repositive Cancer Model network

March 2, 2021

Could Fruit Flies Help Match Patients With Cancer Treatments?

February 26, 2021

Medicision reaches deal to provide avatar-driven precision cancer treatment

September 16, 2020

My Personal Therapeutics and Medivizor Announce a Collaboration Agreement

August 31, 2020

My Personal Therapeutics to Test Fruit Fly Avatar Technology in Gastrointestinal Cancer Patients

July 24, 2020

My Personal Therapeutics awarded grant from Innovate UK to collaborate with the NIHR - London In Vitro Diagnostic Co-operative to provide personalised treatment to patients with Gastro-Intestinal Cancer

July 15, 2020

My Personal Therapeutics and Pentavere scoop funding for lung cancer digital therapeutics

July 3, 2020

My Personal Therapeutics Appoints Jon Waterman-Smith as Vice President of Business Development

July 1, 2020

My Personal Therapeutics (MPT) and Acindes announce an exclusive collaboration agreement

April 27, 2020

GHP News 2020 Biotechnology Awards Winners

April 14, 2020

Building avatar armies with fish and flies

March 24, 2020

Silicon Valley pone en su podio a My Personal Therapeutics: tratamiento de cáncer personalizado

March 9, 2020

myTomorrows collaborates with My Personal Therapeutics

February 19, 2020

Get ready for Global: 7 exciting startups to look out for.

February 7, 2020

A personal “flybrary”

January 27, 2020

London startup enlists fruit flies in fight against cancer

November 25, 2019

Scientists used fruit flies to quickly develop a personalized cancer treatment for a dying man

September 13, 2019

How can the personal discovery process evolve personalized medicine? An interview with Laura Towart

September, 2019

Are fruit fly 'avatars' the next step in personalized medicine?

May 24, 2019

Specially created animal 'cancer avatars' could personalise treatments

May 22, 2019

10 to Watch: Up-and-coming companies fulfilling the promise of precision medicine

May 22, 2019

Fruit fly model provides personalized cancer therapy recommendation

May 22, 2019

A personalized platform identifies trametinib plus zoledronate for a patient with KRAS-mutant metastatic colorectal cancer

May 22, 2019

My Personal Therapeutics announces funding and secures exclusive Mount Sinai School of Medicine technology license to revolutionize personalized cancer treatment

April 30, 2019

My Personal Therapeutics announces funding and secures exclusive Mount Sinai School of Medicine technology license to revolutionize personalized cancer treatment

April 12, 2019